Qiaoli H. Wang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer.

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer.

Journal: Frontiers in immunology

Published: January 16, 2026

Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.

Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.

Journal: Frontiers in immunology

Published: December 22, 2025

Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.

Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.

Journal: Frontiers in immunology

Published: August 27, 2025

Clinical efficacy of drug-coated balloon vs plain balloon in the treatment of restenosis after stenting of femoropopliteal artery occlusive disease with complex long segment combined with severe calcification

Clinical efficacy of drug-coated balloon vs plain balloon in the treatment of restenosis after stenting of femoropopliteal artery occlusive disease with complex long segment combined with severe calcification

Journal: Zhonghua yi xue za zhi

Published: April 28, 2025

Correlation and predictive value analysis of systemic inflammation grade and plaque stability in patients with carotid artery stenosis

Correlation and predictive value analysis of systemic inflammation grade and plaque stability in patients with carotid artery stenosis

Journal: Zhonghua yi xue za zhi

Published: February 16, 2025

An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor Vaccine.

An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor Vaccine.

Journal: Advanced healthcare materials

Published: May 03, 2024

Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V.

Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V.

Journal: Biomolecules & biomedicine

Published: March 04, 2024

Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.

Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.

Journal: Frontiers in immunology

Published: April 23, 2023

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer.

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer.

Journal: Human vaccines & immunotherapeutics

Published: February 22, 2023

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort.

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort.

Journal: Human vaccines & immunotherapeutics

Published: November 22, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026